Navigation Links
Researchers identify potential patient safety risks among methadone maintenance treatment patients
Date:7/8/2009

(Boston) Boston Medical Center (BMC) researchers have identified potential safety risks among methadone maintenance treatment (MMT) patients due to the quantity and accuracy of medical record documentation. Improved communication and coordination among substance use treatment and medical providers could mitigate and manage the potential adverse effects of methadone and interacting medications. The BMC study appears in the July issue of Journal of General Internal Medicine.

MMT is a chronic therapy for opioid dependence, a chronic relapsing disease that often requires lifelong treatment. MMT typically is provided separately from medical care. Ideally, when patients in MMT engage in outpatient or inpatient medical care, treating physicians are aware of MMT and document both methadone on the medication list and opioid dependence on the medical problem list. When this is not done, there is a chance for medication-methadone interactions, which could potentially contribute to clinically significant adverse events, including cardiac arrhythmias, overdoses and decreased cognitive function.

BMC researchers aimed to identify potential patient safety risks among MMT patients engaged in medical care by evaluating the frequency that opioid dependence and MMT documentation were missing in medical records and characterizing potential medication-methadone interactions.

The researchers found documentation of opioid dependence diagnosis was missing from the medical record in 30 percent of subjects; documentation of MMT was missing from either the last discharge summary or last primary care note in 11 percent of subjects; among subjects seen by a primary care doctor, documentation of MMT was missing in 7 percent; among subjects discharged from the inpatient hospital, documentation of MMT was missing in 10 percent. Sixty-nine percent of the study subjects were taking at least one medication that potentially interacted with methadone and 19 percent were taking three or more potentially interacting medications.

"Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients," said lead author Alexander Walley, MD, MSc, general internist in the Clinical Addiction Research and Education Unit at BMC and assistant professor of medicine at Boston University School of Medicine. "Most of these patients are taking prescribed medications that potentially interact with methadone. This study demonstrates opportunities to improve communication, care coordination, and patient safety among patients receiving medical and substance use treatment."


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Purdue researchers create prostate cancer homing device for drug delivery
2. Moles and melanoma -- researchers find genetic links to skin cancer
3. Australian researchers identify genes that cause melanoma
4. Researchers find possible environmental causes for Alzheimers, diabetes
5. IU researchers find vibrator use to be common, linked to sexual health
6. AcademyHealth honors leading health services researchers
7. Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation
8. Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer
9. European researchers look for new ways to fight multi-drug-resistant bacterial infections
10. UAB researchers draft 3-D protein map to aid stroke, cancer research
11. UT School of Public Health researchers develop game for HIV+ youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: